SCHEMBL10950326

SCHEMBL10950326

CCCCc1[nH]c(=O)c(C)cc1-c1ccc(-n2ccnc2)cc1.CCc1[nH]c(=O)c(C)cc1-c1ccc(-n2ccnc2C)cc1.CCc1[nH]c(=O)ccc1-c1ccc(-n2ccnc2)s1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADH5 P11766 6/20 0.35
▸ PDE3B Q13370 5/20 0.34
▸ PDE3A Q14432 5/20 0.34
▸ PDE2A O00408 2/20 0.34
▸ PDE1A P54750 1/20 0.34
▸ PDE1B Q01064 1/20 0.34
▸ PDE1C Q14123 1/20 0.34
▸ PDE4A P27815 4/20 0.34
▸ PDE4B Q07343 4/20 0.34
▸ PDE4C Q08493 4/20 0.34
▸ PDE4D Q08499 4/20 0.34
▸ CYP1A2 P05177 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ CYP19A1 P11511 2/20 0.31
▸ CYP2C9 P11712 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10365547 0.81 PDE4A (0.36) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL10763411 0.79 PDE3B (0.51) ADH5PDE3BPDE3APDE2APDE1A
SCHEMBL10363287 0.77 PDE4A (0.42) ADH5PDE3BPDE3APDE2APDE1A
SCHEMBL10363632 0.75 PDE3B (0.38) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL10365504 0.75 PDE4A (0.40) ADH5PDE3BPDE3APDE2APDE1A
SCHEMBL10762086 0.75 PDE4B (0.52) ADH5PDE3BPDE3APDE2APDE4A
SCHEMBL10756489 0.75 PDE3B (0.55) ADH5PDE3BPDE3APDE2APDE1A
SCHEMBL10763565 0.74 PDE3B (0.53) ADH5PDE3BPDE3APDE2APDE1A
SCHEMBL10363624 0.71 PDE4A (0.37) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL10363623 0.68 PDE4A (0.44) ADH5PDE3BPDE3APDE2APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0175187-A1 3,4-Dihydro-2(1H)-pyridones and 2(1H)-pyridones containing imidazole groups, method for their preparation and medicaments containing them A. Nattermann & Cie. GmbH (DE) 1986-03-26 — — EP disclosed
Send feedback